Gina Consylman

2020 - Ironwood Pharmaceuticals

In 2020, Gina Consylman earned a total compensation of $2.5M as Chief Financial Officer and Senior Vice President at Ironwood Pharmaceuticals, a 29% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$264,652
Salary$512,751
Stock Awards$1,676,402
Other$11,040
Total$2,464,845

Consylman received $1.7M in stock awards, accounting for 68% of the total pay in 2020.

Consylman also received $264.7K in non-equity incentive plan, $512.8K in salary and $11K in other compensation.

Rankings

In 2020, Gina Consylman's compensation ranked 4,613th out of 13,090 executives tracked by ExecPay. In other words, Consylman earned more than 64.8% of executives.

ClassificationRankingPercentile
All
4,613
out of 13,090
65th
Division
Manufacturing
1,875
out of 5,621
67th
Major group
Chemicals And Allied Products
731
out of 2,254
68th
Industry group
Drugs
626
out of 1,954
68th
Industry
Pharmaceutical Preparations
473
out of 1,459
68th

Pay ratio

Gina Consylman's Pay$2,464,845
Median Employee's Pay$222,011
Pay Ratio

11

to 1

In 2020, the annual total compensation of Gina Consylman was $2,464,845.

The annual total compensation of the median employee at Ironwood Pharmaceuticals was $222,011.

The ratio of Gina Consylman's pay to the pay of median employee was therefore 11 to one.

Source: SEC filing on April 22, 2021.

Consylman's colleagues

We found four more compensation records of executives who worked with Gina Consylman at Ironwood Pharmaceuticals in 2020.

2020

Mark Mallon

Ironwood Pharmaceuticals

Chief Executive Officer

2020

Thomas McCourt

Ironwood Pharmaceuticals

Chief Executive Officer

2020

Jason Rickard

Ironwood Pharmaceuticals

Chief Operating Officer

2020

Michael Shetzline

Ironwood Pharmaceuticals

Chief Medical Officer

News

You may also like